Edition:
India

Midatech Pharma PLC (MTP.OQ)

MTP.OQ on NASDAQ Stock Exchange Capital Market

0.76USD
19 Apr 2018
Change (% chg)

$-0.02 (-2.08%)
Prev Close
$0.78
Open
$0.76
Day's High
$0.76
Day's Low
$0.76
Volume
438
Avg. Vol
18,203
52-wk High
$3.18
52-wk Low
$0.74

Latest Key Developments (Source: Significant Developments)

Midatech Pharma Says Approval Of Investigational New Drug Application From US FDA To Conduct Study Of MTX110
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Midatech Pharma Plc ::APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FROM US FDA TO CONDUCT A STUDY OF MTX110.MTX110 IS AN INVESTIGATIONAL NANO-INCLUSION PRODUCT, FOR TREATMENT OF FATAL CHILDHOOD BRAIN CANCER DIPG.  Full Article

Midatech Pharma Enters Into Four-Year Senior Secured Loan Agreement With Midcap Financial Of Up To $15 Mln​
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Midatech Pharma Plc ::MIDATECH PHARMA PLC - ‍HAS ENTERED INTO A FOUR-YEAR SENIOR SECURED LOAN AGREEMENT WITH MIDCAP FINANCIAL OF UP TO $15 MILLION​.  Full Article

Midatech Pharma U.S. Initiates Gelclair Phase IV Trial To Study Oral Mucositis In Stem Cell Transplant Patients
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Midatech Pharma Plc ::MIDATECH PHARMA US INITIATES GELCLAIR® PHASE IV TRIAL TO STUDY ORAL MUCOSITIS IN STEM CELL TRANSPLANT PATIENTS.MIDATECH PHARMA PLC - CO ANTICIPATES THAT PHASE IV TRIAL WILL COMPLETE ENROLLMENT IN H2 OF 2018.  Full Article

BRIEF-Midatech Gets Orphan Drug Designation For Mtd119

* MIDATECH GETS ORPHAN DRUG DESIGNATION FOR MTD119 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

No consensus analysis data available.